NEWS

For our visitors who seek the latest industry news and updates to keep abreast with the goings-on of the business on a global scale, Pharmaceutical Industry portal grants a dynamic and diverse feed of news items.

news

Vertex Pharmaceuticals Inc said it received a subpoena from the U.S. Department of Justice in the third quarter related to its marketed medicines, seeking documents related primarily to its "good laboratory practices" in a bioanalytical lab. Good laboratory practices are rules that govern non-clinical safety studies, ensuring quality, integrity and…

news

Pfizer Inc, the No. 1 U.S. drugmaker, and Botox maker Allergan Plc said they were in friendly talks to create a pharmaceutical colossus but the prospect that the company would seek to avoid U.S. taxes sounded political alarm bells. Both New York-based Pfizer and Dublin-based Allergan said no agreement has…

news

Glenmark Pharmaceuticals today said it has received tentative approval from the US health regulator for its Lacosamide tablets. "Glenmark Pharmaceuticals Inc USA has been granted tentative approval by the United States Food and Drug Administration (USFDA) for its Lacosamide Tablets, 50 mg, 100 mg, 150 mg and 200 mg, the…

news

Teva Pharmaceutical Industries, the world's largest generics drugmaker, reported third-quarter profit that beat estimates and raised its full-year 2015 outlook. Teva, which is in the process of buying Allergan's generic business for $40.5 billion and Mexico's Rimsa for $2.3 billion, said on Thursday it earned $1.35 per share excluding one-time…

news

As drugmakers including Novartis, Juno Therapeutics and Kite Pharma race to launch what may be the most effective treatments ever seen for leukemia and other blood cancers, they are grappling with how to make them widely available in a reliable and cost-efficient way. The new therapies, known as CAR T…

news

Sandoz, the generic drug arm of Swiss drug major Novartis, has received a warning letter from the US health regulator for violations of current good manufacturing practice (cGMP) norms at its two plants in Western India. "On October 22, 2015, the US Food and Drug Administration (USFDA) issued a warning…

news

The U.S. Food and Drug Administration expanded the use of Bristol-Myers Squibb Co's skin cancer drug, Yervoy, as an additional therapy for patients with late-stage melanoma. This approval extends Yervoy's use to patients with stage III melanoma, who have a high risk of recurrence after surgery, the agency said on…

news

Drug major Sun Pharma is recalling over ten lakh boxes of its anti-allergic Loratadine drug from the US market as the lot was found to be 'super potent' and 'out of specification'. As per the information available on the USFDA website, Ohm Laboratories Inc, a unit of Ranbaxy Laboratories, which…

news

GlaxoSmithKline reported better-than-expected earnings on Wednesday, helped by strong demand for HIV drugs and flu vaccines, which offset a further slide in sales of respiratory medicine, sending its shares 3 percent higher. Profits were also boosted by tight cost control, resulting in what Bernstein analyst Tim Anderson described as "the…

news

Plandaí Biotechnology, Inc., producer of the highly bioavailable Phytofare®, today announced that it has executed an Exclusive Distribution Agreement with Bal Pharma Ltd., an India-based manufacturer and exporter of pharmaceutical finished formulation/bulk drugs and distributor of nutraceuticals ingredients (www.balpharma.com). Under the terms of the agreement, Bal Pharma will use the…